China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a report issued on Saturday. The firm issued a hold rating on the stock.

China Pharma Trading Up 11.2 %

NYSE:CPHI opened at $0.20 on Friday. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. China Pharma has a 1-year low of $0.13 and a 1-year high of $0.60. The business’s 50-day moving average price is $0.20 and its two-hundred day moving average price is $0.22.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.